Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
SION-719 Phase 2 Results Expected
SION-719 • Cystic Fibrosis (CF)
Target Indication
Cystic Fibrosis (CF)
Clinical Trial
Last updated: 12/4/2025
SION
Sionna Therapeutics, Inc.